Stuttgart - Delayed Quote EUR
Fate Therapeutics Inc (F6T.SG)
1.1470
-0.0500
(-4.18%)
As of 8:00:43 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-122,874
-122,874
-132,263
-248,208
-162,870
Investing Cash Flow
12,218
12,218
112,665
166,751
-324,023
Financing Cash Flow
99,892
99,892
85
9,207
453,129
End Cash Position
46,283
46,283
57,047
76,560
148,810
Capital Expenditure
-730
-730
-6,153
-35,566
-50,704
Issuance of Capital Stock
74,531
74,531
--
--
411,735
Free Cash Flow
-123,604
-123,604
-138,416
-283,774
-213,574
12/31/2021 - 3/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMR.SG AC Immune SA
1.3560
0.00%
473A.SG Adaptimmune Therapeutics PLC
0.2200
-2.65%
3G0.BE Altimmune Inc
4.3900
-0.48%
2VSA.DU Verastem Inc. R
6.15
-3.15%
PH4.DU CStone Pharmaceuticals
0.3300
+2.48%
MDG1.F Medigene AG
0.1685
-23.06%
TBPH Theravance Biopharma, Inc.
9.45
+1.50%
OCS Oculis Holding AG
17.89
+0.62%
VOR Vor Biopharma Inc.
0.7591
+8.13%
SCPH scPharmaceuticals Inc.
2.6000
-0.38%